Cochrane · systematic review · CD006927
Statins for age‐related macular degeneration
Gehlbach, P, Li, T, Hatef, E · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Statins compared with placebo for age‐related macular degeneration
Population: People aged 50 years or older with age‐related macular degeneration
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Change in visual acuity Statins vs placebo | no estimate extracted | 1 study · 30 participants | Low Downgraded: risk of bias |
Onset and progression of AMD Statins vs placebo | no estimate extracted | 1 study · 114 participants | Low Downgraded: risk of bias |
Adverse outcomes Statins vs placebo | no estimate extracted | 1 study · 114 participants | Low Downgraded: risk of bias |